Jeffrey W. Runge, Director at Aditx Therapeutics, Inc. (ADTX), bought 7,300 shares at $2.94 ($21K) on 2021-06-01, disclosed to the SEC on 2021-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.93 | 1,600 | $5K | 21.9% |
| 2 | $2.93 | 2,000 | $6K | 27.3% |
| 3 | $2.94 | 700 | $2K | 9.6% |
| 4 | $2.94 | 3,000 | $9K | 41.2% |
| Total | $2.94 avg | 7,300 | $21K | 100% |
| Filing → |